Inovio Pharmaceuticals, Inc.
Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy
Last updated:
Abstract:
Disclosed herein is a vaccine comprising an antigen and checkpoint inhibitor. Also disclosed herein is a method for enhancing an immune response in a subject. The method may comprise administering the vaccine to the subject in need thereof.
Status:
Grant
Type:
Utility
Filling date:
28 Jan 2016
Issue date:
14 Sep 2021